There’s so much to detest about the president of the United States, but setting his targets on the pharmaceutical industry might actually turn out to be beneficial for citizens. Maybe.

I’m sure this executive order, like most of his, will be challenged (and rightfully so). His motivation is clearly focused on the US budget rather than benefiting citizens struggling with healthcare costs. However, I wonder if this might actually get the ball rolling with some much much needed reform. One can hope?